Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12610000727044Phase 2Recruiting
Phase 2, randomised, single-blind trial in cataract comparing Melatonin, Gabapentin and Placebo (3 arms). Primary endpoints: Pain during block, surgery, and recovery and Anxiety over perioperative time course. Started Sep 2010; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12610000727044.